메뉴 건너뛰기




Volumn 19, Issue 10, 2016, Pages 1-9

The effects of vortioxetine on cognitive function in patients with major depressive disorder: A meta-Analysis of three randomized controlled trials

Author keywords

Cognitive function; Duloxetine; Major depressive disorder; Meta Analysis; Vortioxetine

Indexed keywords

DULOXETINE; VORTIOXETINE;

EID: 84995578213     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/injp/pyw055     Document Type: Article
Times cited : (150)

References (44)
  • 1
    • 0027361468 scopus 로고
    • The course of geriatric depression with reversible dementia : A controlled study
    • Alexopoulos GS, Meyers BS, Young RC, Mattis S, Kakuma T (1993) The course of geriatric depression with "reversible dementia": A controlled study. Am J Psych 150:1693-1699.
    • (1993) Am J Psych , vol.150 , pp. 1693-1699
    • Alexopoulos, G.S.1    Meyers, B.S.2    Young, R.C.3    Mattis, S.4    Kakuma, T.5
  • 2
    • 0034030898 scopus 로고    scopus 로고
    • Practice guideline for the treatment of patients with major depressive disorder (revision)
    • American Psychiatric Association
    • American Psychiatric Association (2000a) Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psych 157(Supp 4):1-45.
    • (2000) Am J Psych , vol.157 , pp. 1-45
  • 3
    • 84870469320 scopus 로고    scopus 로고
    • American Psychiatric Association, Text revision, 4th ed. Washington, DC: American Psychiatric Association
    • American Psychiatric Association (2000b) Diagnostic and statistical manual of mental disorders. Text revision, 4th ed. Washington, DC: American Psychiatric Association.
    • (2000) Diagnostic and Statistical Manual of Mental Disorders
  • 5
    • 84924210882 scopus 로고    scopus 로고
    • Cognitive dysfunction in major depressive disorder: A state-of-The-Art clinical review
    • Bortolato B, Carvalho AF, McIntyre RS (2014) Cognitive dysfunction in major depressive disorder: A state-of-The-Art clinical review. CNS Neurol Disord Drug Targets 13: 1804-1818.
    • (2014) CNS Neurol Disord Drug Targets , vol.13 , pp. 1804-1818
    • Bortolato, B.1    Carvalho, A.F.2    McIntyre, R.S.3
  • 7
    • 13744252808 scopus 로고    scopus 로고
    • The mediation proportion: A structural equation approach for estimating the proportion of exposure effect on outcome explained by an intermediate variable
    • Ditlevsen S, Christensen U, Lynch J, Damsgaard MT, Keiding N (2005a). The mediation proportion: A structural equation approach for estimating the proportion of exposure effect on outcome explained by an intermediate variable. Epidemiology 16:114-120.
    • (2005) Epidemiology , vol.16 , pp. 114-120
    • Ditlevsen, S.1    Christensen, U.2    Lynch, J.3    Damsgaard, M.T.4    Keiding, N.5
  • 8
    • 13744252808 scopus 로고    scopus 로고
    • The mediation proportion: A structural equation approach for estimating the proportion of exposure effect onoutcome explained by an intermediate variable. Appendix A, The mediation proportion: Details of the basic statistical regression model
    • Ditlevsen S, Christensen U, Lynch J, Damsgaard MT, Keiding N (2005b). The mediation proportion: A structural equation approach for estimating the proportion of exposure effect onoutcome explained by an intermediate variable. Appendix A, The mediation proportion: details of the basic statistical regression model. Epidemiology 16:114-120.
    • (2005) Epidemiology , vol.16 , pp. 114-120
    • Ditlevsen, S.1    Christensen, U.2    Lynch, J.3    Damsgaard, M.T.4    Keiding, N.5
  • 9
    • 84945461623 scopus 로고    scopus 로고
    • The effect of vortioxetine on health-related quality of life in patients with major depressive disorder
    • Florea I, Danchenko N, Brignone M, Loft H, Rive B, Abetz-Webb L (2015) The effect of vortioxetine on health-related quality of life in patients with major depressive disorder. Clin Ther 37:2309-2323.
    • (2015) Clin Ther , vol.37 , pp. 2309-2323
    • Florea, I.1    Danchenko, N.2    Brignone, M.3    Loft, H.4    Rive, B.5    Abetz-Webb, L.6
  • 10
    • 84893051050 scopus 로고    scopus 로고
    • Effects of the multimodal antidepressant Lu AA21004 on rat synaptic and cellular hippocampal plasticity and memory recognition
    • Haddjeri N, Etievant A, Pehrson A, Sanchez C, Betry C (2012) Effects of the multimodal antidepressant Lu AA21004 on rat synaptic and cellular hippocampal plasticity and memory recognition. Eur Neuropsychopharmacol 22:S303.
    • (2012) Eur Neuropsychopharmacol , vol.22 , pp. S303
    • Haddjeri, N.1    Etievant, A.2    Pehrson, A.3    Sanchez, C.4    Betry, C.5
  • 11
    • 84867843308 scopus 로고    scopus 로고
    • Cognitive functioning in major depression -A summary
    • Hammar A, Ardal G (2009) Cognitive functioning in major depression -A summary. Front Hum Neurosci 3:26.
    • (2009) Front Hum, Neurosci , vol.3 , pp. 26
    • Hammar, A.1    Ardal, G.2
  • 13
    • 84862132965 scopus 로고    scopus 로고
    • A randomized, doubleblind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder
    • Katona C, Hansen T, Olsen CK (2012) A randomized, doubleblind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder. Int Clin Psychopharmacol 27:215-223.
    • (2012) Int Clin Psychopharmacol , vol.27 , pp. 215-223
    • Katona, C.1    Hansen, T.2    Olsen, C.K.3
  • 14
  • 15
    • 84919456307 scopus 로고    scopus 로고
    • Cognitive dysfunction in major depressive disorder: Effects on psychosocial functioning and implications for treatment
    • Lam RW, Kennedy SH, Mclntyre RS, Khullar A (2014) Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment. Can J Psychiatry 59:649-654.
    • (2014) Can J Psychiatry , vol.59 , pp. 649-654
    • Lam, R.W.1    Kennedy, S.H.2    Mclntyre, R.S.3    Khullar, A.4
  • 16
    • 84862165867 scopus 로고    scopus 로고
    • A meta-Analysis of cognitive deficits in first-episode major depressive disorder
    • Lee RS, Hermens DF, Porter MA, Redoblado-Hodge MA (2012) A meta-Analysis of cognitive deficits in first-episode Major Depressive Disorder. J Affect Disord 140:113-124.
    • (2012) J Affect Disord , vol.140 , pp. 113-124
    • Lee, R.S.1    Hermens, D.F.2    Porter, M.A.3    Redoblado-Hodge, M.A.4
  • 17
    • 84857099651 scopus 로고    scopus 로고
    • Putting the efficacy of psychiatric and general medicine medication into perspective: Review of meta-Analyses
    • Leucht S, Hierl S, Kissling W, Dold M, Davis JM (2012) Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-Analyses. Br J Psychiatry 200:97-106.
    • (2012) Br J Psychiatry , vol.200 , pp. 97-106
    • Leucht, S.1    Hierl, S.2    Kissling, W.3    Dold, M.4    Davis, J.M.5
  • 18
    • 84930820283 scopus 로고    scopus 로고
    • A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder
    • Mahableshwarkar AR, Zajecka J, Jacobson W, Chen Y, Keefe RS (2015) A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder. Neuropsychopharmacology 40:2025-2037.
    • (2015) Neuropsychopharmacology , vol.40 , pp. 2025-2037
    • Mahableshwarkar, A.R.1    Zajecka, J.2    Jacobson, W.3    Chen, Y.4    Keefe, R.S.5
  • 19
    • 0030781789 scopus 로고    scopus 로고
    • Effects of alcohol and hypnosedative drugs on digit-symbol substitution: Comparison of two different computerized tests
    • Mattila MJ, Mattila-Evenden ME (1997) Effects of alcohol and hypnosedative drugs on digit-symbol substitution: comparison of two different computerized tests. J Psychopharmacol 11:313-317.
    • (1997) J Psychopharmacol , vol.11 , pp. 313-317
    • Mattila, M.J.1    Mattila-Evenden, M.E.2
  • 20
    • 84929460429 scopus 로고    scopus 로고
    • Memantine monotherapy for Alzheimer's disease: A systematic review and meta-Analysis
    • Matsunaga S, Kishi T, Iwata N (2015) Memantine monotherapy for Alzheimer's disease: A systematic review and meta-Analysis. PLOS One 10:e0123289.
    • (2015) PLOS One , vol.10 , pp. e0123289
    • Matsunaga, S.1    Kishi, T.2    Iwata, N.3
  • 22
    • 84938074907 scopus 로고    scopus 로고
    • A randomized, doubleblind, placebo-controlled study of vortioxetine on cognitive function in depressed adults
    • McIntyre RS, Lophaven S, Olsen CK (2014) A randomized, doubleblind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. Int J Neuropsychop 17:1557-1567.
    • (2014) Int J Neuropsychop , vol.17 , pp. 1557-1567
    • McIntyre, R.S.1    Lophaven, S.2    Olsen, C.K.3
  • 25
  • 26
    • 0018425438 scopus 로고
    • A new depression scale designed to be sensitive to change
    • Montgomery S, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-389.
    • (1979) Br J Psychiatry , vol.134 , pp. 382-389
    • Montgomery, S.1    Asberg, M.2
  • 27
    • 84995608269 scopus 로고    scopus 로고
    • National Academies of Sciences, Engineering, and Medicine . Workshop summary. Washington, DC: National Academies Press (US). Available at:, Accessed October 2015
    • National Academies of Sciences, Engineering, and Medicine (2015). Enabling discovery, development, and translation of treatments for cognitive dysfunction in depression. Workshop summary. Washington, DC: National Academies Press (US). Available at: www.ncbi.nlm.nih.gov/books/NBK305332/pdf/Bookshelf-NBK305332.pdf. Accessed October 2015.
    • (2015) Enabling Discovery, Development, and Translation of Treatments for Cognitive Dysfunction in Depression
  • 28
    • 69649098040 scopus 로고    scopus 로고
    • Canadian network for mood and anxiety treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management
    • Canadian Network for Mood and Anxiety Treatments
    • Patten SB, Kennedy SH, Lam RW, O'Donovan C, Filteau MJ, Parikh SV, Ravindran AV; Canadian Network for Mood and Anxiety Treatments (2009) Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management. J Affect Disord 117(Suppl 1):S5-14.
    • (2009) J Affect Disord , vol.117 , pp. S5-14
    • Patten, S.B.1    Kennedy, S.H.2    Lam, R.W.3    O'Donovan, C.4    Filteau, M.J.5    Parikh, S.V.6    Ravindran, A.V.7
  • 29
    • 0035222398 scopus 로고    scopus 로고
    • UCSD performance-based skills Assessment: Development of a new measure of everyday functioning for severely mentally ill adults
    • Patterson TL, Goldman S, McKibbin CL, Hughs T, Jeste DV (2001) UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull 27:235-245.
    • (2001) Schizophr Bull , vol.27 , pp. 235-245
    • Patterson, T.L.1    Goldman, S.2    McKibbin, C.L.3    Hughs, T.4    Jeste, D.V.5
  • 30
    • 84925584026 scopus 로고    scopus 로고
    • Treatment of cognitive dysfunction in major depressive disorder -A review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors and the multimodal-Acting antidepressant vortioxetine
    • Pehrson AL, Leiser SC, Gulinello M, Dale E, Li Y, Waller JA, Sanchez C (2015) Treatment of cognitive dysfunction in major depressive disorder -A review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors and the multimodal-Acting antidepressant vortioxetine. Eur J Pharmacol 753:19-31.
    • (2015) Eur J Pharmacol , vol.753 , pp. 19-31
    • Pehrson, A.L.1    Leiser, S.C.2    Gulinello, M.3    Dale, E.4    Li, Y.5    Waller, J.A.6    Sanchez, C.7
  • 32
    • 34250832737 scopus 로고    scopus 로고
    • Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: An 8-week, double-blind, placebo-controlled trial
    • Raskin J, Wiltse C, Siegal A, Sheikh J, Xu J, Dinkel JJ, Rotz BT, Mohs RC (2007) Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: An 8-week, double-blind, placebo-controlled trial. Am J Psych 164:900-909.
    • (2007) Am J Psych , vol.164 , pp. 900-909
    • Raskin, J.1    Wiltse, C.2    Siegal, A.3    Sheikh, J.4    Xu, J.5    Dinkel, J.J.6    Rotz, B.T.7    Mohs, R.C.8
  • 33
    • 84893092230 scopus 로고    scopus 로고
    • Role of 5-HT3 receptors in the mechanism of action of the investigational antidepressant vortioxetine
    • Riga MS, Celada P, Sanchez C, Artigas F (2013) Role of 5-HT3 receptors in the mechanism of action of the investigational antidepressant vortioxetine. Eur Neuropsychopharmacol 23:S393-S394.
    • (2013) Eur Neuropsychopharmacol , vol.23 , pp. S393-S394
    • Riga, M.S.1    Celada, P.2    Sanchez, C.3    Artigas, F.4
  • 34
    • 84902260775 scopus 로고    scopus 로고
    • Cognitive impairment in depression: A systematic review and metaanalysis
    • Rock PL, Roiser JP, Riedel WJ, Blackwell AD (2014) Cognitive impairment in depression: A systematic review and metaanalysis. Psychol Med 44:2029-2040.
    • (2014) Psychol Med , vol.44 , pp. 2029-2040
    • Rock, P.L.1    Roiser, J.P.2    Riedel, W.J.3    Blackwell, A.D.4
  • 35
    • 85016923557 scopus 로고    scopus 로고
    • The cognitive effects of antidepressants in major depressive disorder: A systematic review and meta-Analysis of randomized clinical trials
    • Rosenblat JD, Kakar R, McIntyre RS (2015) The cognitive effects of antidepressants in major depressive disorder: A systematic review and meta-Analysis of randomized clinical trials. Int J Neuropsychop. Advance online publication. doi:10.1093/ijnp/pyv082.
    • (2015) Int J Neuropsychop. Advance Online Publication
    • Rosenblat, J.D.1    Kakar, R.2    McIntyre, R.S.3
  • 37
    • 34249934224 scopus 로고    scopus 로고
    • Long-Term outcome of depressive pseudodementia in the elderly
    • Saez-Fonseca JA, Lee L, Walker Z (2007) Long-Term outcome of depressive pseudodementia in the elderly. J Affect Disord 101:123-129.
    • (2007) J Affect Disord , vol.101 , pp. 123-129
    • Saez-Fonseca, J.A.1    Lee, L.2    Walker, Z.3
  • 38
    • 84918785170 scopus 로고    scopus 로고
    • Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data
    • Sanchez C, Asin K, Artigas F (2015) Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data. Pharmacol Ther 145:43-57.
    • (2015) Pharmacol Ther , vol.145 , pp. 43-57
    • Sanchez, C.1    Asin, K.2    Artigas, F.3
  • 39
    • 84886283870 scopus 로고    scopus 로고
    • Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: A meta-Analysis and review
    • Snyder HR (2013) Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: A meta-Analysis and review. Psychol Bull 139:81-132.
    • (2013) Psychol Bull , vol.139 , pp. 81-132
    • Snyder, H.R.1
  • 40
    • 84860231272 scopus 로고    scopus 로고
    • Patient safety considerations in the rehabilitation of the individual with cognitive impairment
    • Tyson BT, Pham MT, Brown NT, Mayer TR (2012) Patient safety considerations in the rehabilitation of the individual with cognitive impairment. Phys Med Rehabil Clin N Am 23:315-334.
    • (2012) Phys Med Rehabil Clin N Am , vol.23 , pp. 315-334
    • Tyson, B.T.1    Pham, M.T.2    Brown, N.T.3    Mayer, T.R.4
  • 41
    • 84930247852 scopus 로고    scopus 로고
    • Vortioxetine restores reversal learning impaired by 5-HT depletion or chronic intermittent cold stress in rats
    • Wallace A, Pehrson AL, Sanchez C, Morilak DA (2014) Vortioxetine restores reversal learning impaired by 5-HT depletion or chronic intermittent cold stress in rats. Int J Neuropsychop 17:1695-1706.
    • (2014) Int J Neuropsychop , vol.17 , pp. 1695-1706
    • Wallace, A.1    Pehrson, A.L.2    Sanchez, C.3    Morilak, D.A.4
  • 44
    • 84946573476 scopus 로고    scopus 로고
    • The impact of cognitive impairment and comorbid depression on disability, health care utilization, and costs
    • Xiang X, An R (2015) The impact of cognitive impairment and comorbid depression on disability, health care utilization, and costs. Psychiatr Serv 66:1245-1248.
    • (2015) Psychiatr Serv , vol.66 , pp. 1245-1248
    • Xiang, X.1    An, R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.